标普和纳斯达克内在价值 联系我们

Global Roundtable Corporation GRCU OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Global Roundtable Corporation (GRCU) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 34/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
36/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
25/100
→ Income
健康
17/100
Debt-to-Equity & liquidity
→ Health
护城河
36/100
→ Income
成长
90/100
→ Income
收入
10/100
→ Income

估值概览 — GRCU

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.54
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2015 $-0.01 $20.2K $-95.62K -473.4%
2016 $-0.01 $6.8K $-2.78M -40875.7%
2017 $0.00 $112.96K $51.61K 45.7%
2018 $0.00 $142.52K $66.75K 46.8%
2019 $0.00 $182.83K $63.06K 34.5%
2020 $0.00 $191.67K $10.12K 5.3%
2021 $0.00 $135.86K $-520.75K -383.3%
2022 $0.00 $102.08K $-452.05K -442.8%
2023 $0.00 $2.36M $408.83K 17.4%
2024 $0.00 $1.3M $-243.23K -18.7%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言